ANG Lifesciences India Limited (BOM:540694)

India · Delayed Price · Currency is INR

34.09

+0.66 (1.97%)

At close: Sep 4, 2026

Market Cap	445.16M +35.0%
Revenue (ttm)	n/a -36.5%
Net Income	n/a
EPS	n/a
Shares Out	13.06M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,365
Open	34.09
Previous Close	33.43
Day's Range	33.40 - 34.09
52-Week Range	17.63 - 49.69
Beta	0.65
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About ANG Lifesciences India

ANG Lifesciences India Limited engages in manufacturing and sale of finished pharmaceutical formulations in India and internationally. Its product portfolio comprises therapeutics categories, such as antibiotics, antiviral, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, and beta lactamase inhibitor. The company offers its finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials, liquid injection vials, ampoules, PFS, hard gelatin capsules, soft gelatin capsules, dry syrups, liquid syrups and ... [Read more]

Industry Pharmaceutical Preparations

Founded 2006

Employees 412

Stock Exchange Bombay Stock Exchange

Ticker Symbol 540694

Full Company Profile

Financial Performance

In fiscal year 2025, ANG Lifesciences India's revenue was 928.47 million, a decrease of -36.45% compared to the previous year's 1.46 billion. Losses were -124.13 million, 22.4% more than in 2024.

Financial Statements